News & Publications
Publication
AACR Poster 2025 (R800)
GO Therapeutics
|May 6, 2025
Publication
AACR Poster 2025 (L100)
GO Therapeutics
|May 6, 2025
Media Highlights
Era of ADCs: Pharma companies innovate to stand out in a buzzing market
Pharma Technology Focus
|December 10, 2024
Press Release
Clarivate ADC Companies to Watch 2024
Clarivate
|September 4, 2024
Publication
PEGS Poster 2024
GO Therapeutics
|September 4, 2024
Publication
AACR Poster 2024
GO Therapeutics
|September 4, 2024
Publication
New publication on glyco-CARTs for the treatment of solid cancers
AACR Journals
|September 15, 2023
Publication
GO Therapeutics CSO review on site-specific O-glycans in human tissue formation, O-glycan occupancy, and contributions from individual GalNAc-Ts
Nature
|October 21, 2022
Press Release
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
Astellas
|June 1, 2022
Press Release
Clarivate ADC Companies to Watch 2024
Clarivate
|September 4, 2024
Press Release
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
Astellas
|June 1, 2022
Press Release
GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment
October 2, 2018
Publication
AACR Poster 2025 (R800)
GO Therapeutics
|May 6, 2025
Publication
AACR Poster 2025 (L100)
GO Therapeutics
|May 6, 2025
Publication
PEGS Poster 2024
GO Therapeutics
|September 4, 2024
Publication
AACR Poster 2024
GO Therapeutics
|September 4, 2024
Publication
New publication on glyco-CARTs for the treatment of solid cancers
AACR Journals
|September 15, 2023
Publication
GO Therapeutics CSO review on site-specific O-glycans in human tissue formation, O-glycan occupancy, and contributions from individual GalNAc-Ts
Nature
|October 21, 2022